scholarly journals Pulsatile Cerebrospinal Fluid and Plasma Ghrelin in Relation to Growth Hormone Secretion and Food Intake in the Sheep

2008 ◽  
Vol 20 (10) ◽  
pp. 1138-1146 ◽  
Author(s):  
D. Grouselle ◽  
E. Chaillou ◽  
A. Caraty ◽  
M.-T. Bluet-Pajot ◽  
P. Zizzari ◽  
...  
2007 ◽  
Vol 39 (Supplement) ◽  
pp. S488-S489
Author(s):  
Koji Toshinai ◽  
Muhtashan S. Mondal ◽  
Takuya Shimbara ◽  
Hideki Yamaguchi ◽  
Yukari Date ◽  
...  

2007 ◽  
Vol 22 (5) ◽  
pp. 1309-1313 ◽  
Author(s):  
O. Alvarez-Garcia ◽  
E. Garcia-Lopez ◽  
J. Rodriguez ◽  
H. Gil-Pena ◽  
I. Molinos ◽  
...  

Peptides ◽  
2005 ◽  
Vol 26 (10) ◽  
pp. 1720-1727 ◽  
Author(s):  
Amanda M. Shaw ◽  
Boman G. Irani ◽  
Marcus C. Moore ◽  
Carrie Haskell-Luevano ◽  
William J. Millard

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Christine Delporte

Ghrelin is the natural ligand of the growth hormone secretagogue receptor (GHS-R1a). Ghrelin is a 28 amino acid peptide possessing a unique acylation on the serine in position 3 catalyzed by ghrelinO-acyltransferase (GOAT). Ghrelin stimulates growth hormone secretion, but also appetite, food intake, weight gain, and gastric emptying. Ghrelin is involved in weight regulation, obesity, type 2 diabetes, and metabolic syndrome. Furthermore, a better understanding of ghrelin biology led to the identification of molecular targets modulating ghrelin levels and/or its biological effects: GOAT, ghrelin, and GHS-R1a. Furthermore, a recent discovery, showing the involvement of bitter taste receptor T2R in ghrelin secretion and/or synthesis and food intake, suggested that T2R could represent an additional interesting molecular target. Several classes of ghrelin-related pharmacological tools for the treatment of obesity have been or could be developed to modulate the identified molecular targets.


2007 ◽  
Vol 128 (2) ◽  
pp. 182-186 ◽  
Author(s):  
K TOSHINAI ◽  
M MONDAL ◽  
T SHIMBARA ◽  
H YAMAGUCHI ◽  
Y DATE ◽  
...  

Endocrinology ◽  
2000 ◽  
Vol 141 (11) ◽  
pp. 4325-4328 ◽  
Author(s):  
A. M. Wren ◽  
C. J. Small ◽  
H. L. Ward ◽  
K. G. Murphy ◽  
C. L. Dakin ◽  
...  

Endocrinology ◽  
2007 ◽  
Vol 148 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Rubén Nogueiras ◽  
Paul Pfluger ◽  
Sulay Tovar ◽  
Myrtha Arnold ◽  
Sharon Mitchell ◽  
...  

Ghrelin stimulates food intake and adiposity and thereby increases body weight (BW) in rodents after central as well as peripheral administration. Recently, it was discovered that the gene precursor of ghrelin encoded another secreted and bioactive peptide named obestatin. First reports appeared to demonstrate that this peptide requires an amidation for its biological activity and acts through the orphan receptor, GPR-39. Obestatin was shown to have actions opposite to ghrelin on food intake, BW, and gastric emptying. In the present study, we failed to observe any effect of obestatin on food intake, BW, body composition, energy expenditure, locomotor activity, respiratory quotient, or hypothalamic neuropeptides involved in energy balance regulation. In agreement with the first report, we were unable to find any effect of obestatin on GH secretion in vivo. Moreover, we were unable to find mRNA expression of GPR-39, the putative obestatin receptor, in the hypothalamus of rats. Therefore, the results presented here do not support a role of the obestatin/GPR-39 system in the regulation of energy balance.


Sign in / Sign up

Export Citation Format

Share Document